Table 3.

Changes of Dopaminergic Markers in Peripheral Blood Lymphocytes in other Neurological Disorders. The Table Summarizes the Methodology Applied and the Findings Obtained. DA=Dopamine, DAT=Dopamine Transporter, DBH=Dopamine-Beta-Hydroxylase

Authors	Methodology	Disease	Findings
Czlonkowski et al. [76]	Receptor binding assay	Wilson's disease	Decreased D2-like receptor
	Receptor binding assay	Wilson's disease	Decreased D2-like binding
Buttarelli et al. [86]	Immunochemistry	Multiple system atrophy	Decreased DAT immunoreactivity
Buttarelli et al. [87]	Immunochemistry	Amyotrophic lateral sclerosis	Decreased DAT immunoreactivity
Ferrari et al. [90]	Receptor binding assay	Tourette's syndrome	Increased D5 receptor
Barbanti et al. [91]	Receptor binding assay	Alzheimer's disease	Decreased D2-like receptors
Giubilei et al. [92]	Immunochemistry	Alzheimer's disease	Increased DBH immunoreactivity
Barbanti et al. [93]	Receptor binding assay	Migraine	Increased D5 receptors
Barbanti et al. [94]	Receptor binding assay	Migraine	Increased D3, D4 receptors